1 |
Walsh-Reitz MM, Huang EF, Musch MW, Chang EB, Martin TE, Kartha S, et al. AMP-18 protects barrier function of colonic epithelial cells: role of tight junction proteins. Am J Physiol Gastrointest Liver Physiol 2005; 289(1): G163-G171.
DOI
|
2 |
Araki Y, Sugihara H, Hattori T. In vitro effects of dextran sulfate sodium on a Caco-2 cell line and plausible mechanisms for dextran sulfate sodium-induced colitis. Oncol Rep 2006; 16(6): 1357-1362.
|
3 |
Johansson ME, Gustafsson JK, Sjoberg KE, Petersson J, Holm L, Sjovall H, et al. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One 2010; 5(8): e12238.
DOI
|
4 |
Morgan ME, Zheng B, Koelink PJ, van de Kant HJ, Haazen LC, van Roest M, et al. New perspective on dextran sodium sulfate colitis: antigen-specific T cell development during intestinal inflammation. PLoS One 2013; 8(7): e69936.
DOI
|
5 |
Forbes E, Murase T, Yang M, Matthaei KI, Lee JJ, Lee NA, et al. Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J Immunol 2004; 172(9): 5664-5675.
DOI
|
6 |
Choi IY, Lee KT, Kim MC, Kim SJ, Kim DS, Jeon YD, et al. Anti-inflammatory effects of Cheongilppong on DSS-induced ulcerative colitis in mice. Orient Pharm Exp Med 2011; 11(1): 35-39.
DOI
|
7 |
Scott RJ, Hall PA, Haldane JS, van Noorden S, Price Y, Lane DP, et al. A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol 1991; 165(2): 173-178.
DOI
|
8 |
Min HY, Chung HJ, Kim EH, Kim S, Park EJ, Lee SK. Inhibition of cell growth and potentiation of tumor necrosis factor- (TNF-)-induced apoptosis by a phenanthroindolizidine alkaloid antofine in human colon cancer cells. Biochem Pharmacol 2010; 80(9): 1356-1364.
DOI
|
9 |
Janssen-Heininger YM, Poynter ME, Baeuerle PA. Recent advances towards understanding redox mechanisms in the activation of nuclear factor . Free Radic Biol Med 2000; 28(9): 1317-1327.
DOI
|
10 |
Kinoshita T, Ito H, Miki C. Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma. Cancer 1999; 85(12): 2526-2531.
DOI
|
11 |
Schulze-Osthoff K, Ferrari D, Riehemann K, Wesselborg S. Regulation of NF- activation by MAP kinase cascades. Immunobiology 1997; 198(1-3): 35-49.
DOI
|
12 |
Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, et al. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut 2005; 54(3): 364-368.
DOI
|
13 |
Yang SK, Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis 2001; 7(3): 260-270.
DOI
|
14 |
Hoffmann A, Leung TH, Baltimore D. Genetic analysis of NF-/Rel transcription factors defines functional specificities. EMBO J 2003; 22(20): 5530-5539.
DOI
|
15 |
Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009; 361(21): 2066-2078.
DOI
|
16 |
Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48(4): 526-535.
DOI
|
17 |
Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994; 35(11): 1590-1592.
DOI
|
18 |
van Hogezand RA, Eichhorn RF, Choudry A, Veenendaal RA, Lamers CB. Malignancies in inflammatory bowel disease: fact or fiction? Scand J Gastroenterol Suppl 2002; 37(236): 48-53.
DOI
|
19 |
Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res 2016; 14(2): 111-119.
DOI
|
20 |
Yang DH, Yang SK. Trends in the incidence of ulcerative colitis in Korea. Korean J Med 2009; 76(6): 637-642.
|
21 |
Medzhitov R, Janeway CA Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 1997; 9(1): 4-9.
DOI
|
22 |
Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420(6917): 860-867.
DOI
|
23 |
Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002; 15(1): 79-94.
DOI
|
24 |
Jang YJ, Leem HH, Jeon YH, Lee DH, Choi SW. Isolation and identification of -glucosidase inhibitors from morus root bark. J Korean Soc Food Sci Nutr 2015; 44(7): 1090-1099.
DOI
|
25 |
Choi SW, Jang YJ, Lee YJ, Leem HH, Kim EO. Analysis of functional constituents in mulberry (Morus alba L.) twigs by different cultivars, producing areas, and heat processings. Prev Nutr Food Sci 2013; 18(4): 256-262.
DOI
|
26 |
Zhang Z, Shi L. Anti-inflammatory and analgesic properties of cis-mulberroside A from Ramulus mori. Fitoterapia 2010; 81(3): 214-218.
DOI
|
27 |
Chung KO, Kim BY, Lee MH, Kim YR, Chung HY, Park JH, et al. In-vitro and in-vivo anti-inflammatory effect of oxyresveratrol from Morus alba L. J Pharm Pharmacol 2003; 55(12): 1695-1700.
DOI
|
28 |
Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69(2): 238-249.
|
29 |
Su C, Lichtenstein GR. Ulcerative colitis. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. Volume 2. 8th edition. Philadelphia (PA): Saunders; 2006. p.2499-2548.
|
30 |
Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010; 105(3): 501-523.
DOI
|
31 |
Choi CH, Moon W, Kim YS, Kim ES, Lee BI, Jung Y, et al. Second Korean guideline for the management of ulcerative colitis. Korean J Gastroenterol 2017; 69(1): 1-28.
DOI
|
32 |
Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98(3): 694-702.
DOI
|